Page last updated: 2024-08-23

rolafagrel and Diabetic Glomerulosclerosis

rolafagrel has been researched along with Diabetic Glomerulosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessandrini, P; Barrow, SE; De Cosmo, S; Jones, SL; Kontessis, PS; Ritter, JM; Stratton, PD; Viberti, GC1
Alessandrini, P; Ciabattoni, G; Patrono, C; Pugliese, F; Salvati, P1

Trials

1 trial(s) available for rolafagrel and Diabetic Glomerulosclerosis

ArticleYear
Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    The Journal of laboratory and clinical medicine, 1993, Volume: 121, Issue:3

    Topics: Adult; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Drug Administration Schedule; Electrolytes; Female; Glomerular Filtration Rate; Humans; Imidazoles; Immunoglobulin G; Kidney; Male; Middle Aged; Naphthalenes; Proteinuria; Renal Circulation; Thromboxane B2; Thromboxane-A Synthase; Urea

1993

Other Studies

1 other study(ies) available for rolafagrel and Diabetic Glomerulosclerosis

ArticleYear
Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21B

    Topics: Adult; Aged; Animals; Blood Platelets; Diabetic Nephropathies; Female; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Glomerulus; Male; Middle Aged; Naphthalenes; Rats; Rats, Inbred Strains; Thromboxane-A Synthase

1991